Gennadios Aristippos

Gennadios Aristippos is listed in filings as Group Pres. Pharma & Consumer at Catalent Inc. This profile follows SEC Form 4 activity through Dec 18, 2024, including sale activity. Recent filings connect the profile to Catalent Inc (CTLT). The current snapshot covers public activity from Jul 30, 2024 to Dec 18, 2024. Reported amounts are shown as $69.6K to $20.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.